Skip to Content

B854 (Repaglinide 1 mg)

Pill with imprint B854 is Yellow, Round and has been identified as Repaglinide 1 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 1 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B854

Repaglinide 1 mg B854

Repaglinide

Imprint
B854
Strength
1 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Meglitinides
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
51991-0854

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.